Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

completed250%
not_yet_recruiting125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruiting

Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients

NCT07785531
completed

Effects of Surgical, Percutaneous or Medical Treatments for Coronary Artery Disease on Renal Function: Long-Term Outcome. Cardiorenal-trial.

NCT07195747
recruiting

Improving Patient Assessment After Acute Kidney Injury (AKI)

NCT07569588
completedphase_2

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis

NCT00005766

Clinical Trials (4)

Showing 4 of 4 trials
NCT07785531

Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients

Not Yet Recruiting
NCT07195747

Effects of Surgical, Percutaneous or Medical Treatments for Coronary Artery Disease on Renal Function: Long-Term Outcome. Cardiorenal-trial.

Completed
NCT07569588

Improving Patient Assessment After Acute Kidney Injury (AKI)

Recruiting
NCT00005766Phase 2

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4